Emma Bedoukian

ORCID: 0000-0003-3064-2488
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genomics and Rare Diseases
  • Genomic variations and chromosomal abnormalities
  • Retinal Development and Disorders
  • Genetics and Neurodevelopmental Disorders
  • Retinal Diseases and Treatments
  • Congenital heart defects research
  • Hedgehog Signaling Pathway Studies
  • Cancer Genomics and Diagnostics
  • Genetic Syndromes and Imprinting
  • Retinal and Macular Surgery
  • Autism Spectrum Disorder Research
  • Ear Surgery and Otitis Media
  • Glaucoma and retinal disorders
  • Epigenetics and DNA Methylation
  • Genomics and Chromatin Dynamics
  • Renal and related cancers
  • RNA modifications and cancer
  • Cellular transport and secretion
  • Hearing, Cochlea, Tinnitus, Genetics
  • Cardiomyopathy and Myosin Studies
  • Metabolism and Genetic Disorders
  • Biochemical and Molecular Research
  • Ubiquitin and proteasome pathways
  • Congenital limb and hand anomalies
  • Drug-Induced Ocular Toxicity

Children's Hospital of Philadelphia
2016-2025

University of Pennsylvania
2016-2024

Medical Genetics Center
2018-2020

National Institute of Health
2020

University of British Columbia
2019

Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases
2019

Institute of Molecular Biotechnology
2019

Austrian Academy of Sciences
2019

Clinical exome sequencing (CES) has a reported diagnostic yield of 20% to 30% for most clinical indications. The ongoing discovery novel gene-disease and variant-disease associations are expected increase the CES. Performing systematic reanalysis previously nondiagnostic CES samples represents significant challenge laboratories. Here, we present results automated methodology applied 300 initially analyzed between June 2014 September 2016. Application our reduced variant analysis burden by...

10.1016/j.jmoldx.2018.07.008 article EN cc-by-nc-nd Journal of Molecular Diagnostics 2018-12-18
Sarah E. Sheppard Ian M. Campbell Margaret Harr Nina B. Gold Dong Li and 95 more Hans T. Björnsson Julie S. Cohen Jill A. Fahrner Ali Fatemi Jacqueline Harris C. Nowak Cathy A. Stevens Katheryn Grand Margaret Au John M. Graham Pedro A. Sanchez‐Lara Miguel Del Campo Marilyn C. Jones Omar Abdul‐Rahman Fowzan S. Alkuraya Jennifer A. Bassetti Katherine Bergstrom Elizabeth Bhoj Sarah Dugan Julie Kaplan Nada Derar Karen W. Gripp Natalie Hauser A. Micheil Innes Beth Keena Neslida Kodra Rebecca L. Miller Beverly Nelson Małgorzata J.M. Nowaczyk Zuhair Rahbeeni Shay Ben‐Shachar Joseph T.C. Shieh Anne Slavotinek Andrew K. Sobering Mary‐Alice Abbott Dawn C. Allain Louise Amlie‐Wolf Ping Yee Billie Au Emma Bedoukian Geoffrey Beek James S. Barry Janet Berg Jonathan A. Bernstein Cheryl Cytrynbaum Brian Hon‐Yin Chung Sarah Donoghue Naghmeh Dorrani Alison Eaton Josue A. Flores‐Daboub Holly Dubbs Carolyn A. Felix Chin‐To Fong Jasmine Lee Fong Fung Balram Gangaram Amy Goldstein Rotem Greenberg Thoa K. Ha Joseph H. Hersh Kosuke Izumi Staci Kallish Elijah Kravets Pui‐Yan Kwok Rebekah Jobling Amy E. Knight Johnson Jessica D. Kushner Bo Hoon Lee Brooke Levin Kristin Lindstrom Kandamurugu Manickam Rebecca Mardach Elizabeth M. McCormick D. Ross McLeod Frank Mentch Kelly Q. Minks Colleen Muraresku Stanley F. Nelson Patrizia Porazzi Pavel N. Pichurin Nina Powell‐Hamilton Zöe Powis Alyssa Ritter Caleb Rogers Luis Rohena Carey Ronspies Audrey Schroeder Zornitza Stark Lois J. Starr Joan M. Stoler Pim Suwannarat Milen Velinov Rosanna Weksberg Yael Wilnai Neda Zadeh Dina J. Zand Marni J. Falk

Abstract Wiedemann‐Steiner syndrome (WSS) is an autosomal dominant disorder caused by monoallelic variants in KMT2A and characterized intellectual disability hypertrichosis. We performed a retrospective, multicenter, observational study of 104 individuals with WSS from five continents to characterize the clinical molecular spectrum diverse populations, identify physical features that may be more prevalent White versus Black Indigenous People Color individuals, delineate genotype–phenotype...

10.1002/ajmg.a.62124 article EN American Journal of Medical Genetics Part A 2021-03-30

Despite substantial progress in sequencing, current strategies can genetically solve only approximately 55-60% of inherited retinal degeneration (IRD) cases. This be partially attributed to elusive mutations the known IRD genes, which are not easily identified by targeted next-generation sequencing (NGS) or Sanger approaches. We hypothesized that copy-number variations (CNVs) a major contributor genetic causality IRDs.Twenty-eight cases previously unsolved with NGS were investigated...

10.1038/gim.2016.158 article EN publisher-specific-oa Genetics in Medicine 2016-10-13
Benjamin Cogné Sophie Ehresmann Éliane Beauregard‐Lacroix Justine Rousseau Thomas Besnard and 95 more Thomas X. Garcia Slavé Petrovski Shiri Avni Kirsty McWalter Patrick R. Blackburn Stephan Sanders Kévin Uguen Jacqueline Harris Julie S. Cohen Moira Blyth Anna Lehman Jonathan Berg Mindy Li Usha Kini Shelagh Joss Charlotte von der Lippe Christopher T. Gordon Jennifer Humberson Laurie Robak Daryl A. Scott V. Reid Sutton Cara Skraban Jennifer J. Johnston Annapurna Poduri Magnus Nordenskjöld Vandana Shashi Erica H. Gerkes Ernie M.H.F. Bongers Christian Gilissen Yuri A. Zárate Malin Kvarnung Kevin P. Lally Peggy Kulch Brina Daniels Andrés Hernández Nicholas Stong Julie McGaughran Kyle Retterer Kristian Tveten Jennifer A. Sullivan Madeleine R. Geisheker Asbjørg Stray‐Pedersen Jennifer Tarpinian Eric W. Klee Julie C. Sapp Jacob Zyskind Øystein L. Holla Emma Bedoukian Francesca Filippini Anne Guimier A. Picard Øyvind L. Busk Jaya Punetha Rolph Pfundt Anna Lindstrand Ann Nordgren Fayth M. Kalb Megha Desai Ashley H. Ebanks Shalini N. Jhangiani Tammie Dewan Zeynep Coban‐Akdemir Aida Telegrafi Elaine H. Zackai Amber Begtrup Xiaofei Song Annick Toutain Ingrid M. Wentzensen Sylvie Odent Dominique Bonneau Xénia Latypova Wallid Deb Sylvia Redon Frédéric Bilan Marine Legendre Caitlin Troyer Kerri Whitlock Oana Caluseriu Marine I. Murphree Pavel N. Pichurin Katherine Agre Ralitza H. Gavrilova Tuula Rinne Meredith Park Catherine Shain Erin L. Heinzen Rui Xiao Jeanne Amiel Stanislas Lyonnet Bertrand Isidor Leslie G. Biesecker Dan Lowenstein Jennifer E. Posey Anne‐Sophie Denommé‐Pichon Claude Férec

10.1016/j.ajhg.2019.01.010 article EN publisher-specific-oa The American Journal of Human Genetics 2019-03-01

The SLC12 gene family consists of SLC12A1-SLC12A9, encoding electroneutral cation-coupled chloride co-transporters. SCL12A2 has been shown to play a role in corticogenesis and therefore represents strong candidate neurodevelopmental disorder gene. Through trio exome sequencing we identified de novo mutations SLC12A2 six children with disorders. All had developmental delay or intellectual disability ranging from mild severe. Two sensorineural deafness. We also variants three individuals...

10.1093/brain/awaa176 article EN Brain 2020-05-12

Hearing loss is a relatively common condition in children, occurring approximately 2 out of every 1,000 births with 50% reported diagnoses having primary genetic etiology. Given the prevalence and component hearing loss, coupled trend toward early diagnosis institution universal newborn screening, The Genetics Loss Clinic was established at Children's Hospital Philadelphia to manage diagnosis, testing, counseling for individuals families. This paper described cohort 660 evaluated between...

10.1002/ajmg.a.37855 article EN American Journal of Medical Genetics Part A 2016-08-02

Kaufman oculocerebrofacial syndrome (KOS) is a recessive neurodevelopmental disorder characterized by intellectual disability and lack of speech. KOS caused inactivating mutations in UBE3B, but the underlying biological mechanisms are completely unknown. We found that loss Ube3b mice resulted growth retardation, decreased grip strength, vocalization. The brains Ube3b-/- had hypoplasia corpus callosum, enlarged ventricles, thickness somatosensory cortex. cortical neurons abnormal dendritic...

10.1073/pnas.1818751116 article EN Proceedings of the National Academy of Sciences 2019-02-11

We aim to characterize the causality and molecular functional underpinnings of HACE1 deficiency in a mouse model recessive neurodevelopmental syndrome called spastic paraplegia psychomotor retardation with or without seizures (SPPRS).By exome sequencing, we identified 2 novel homozygous truncating mutations 3 patients from families, p.Q209* p.R332*. Furthermore, performed detailed phenotypic analyses Hace1 knock-out (KO) mice SPPRS patient fibroblasts.We show that KO display many clinical...

10.1212/nxg.0000000000000330 article EN cc-by-nc-nd Neurology Genetics 2019-05-01

Methods Two sisters ages 16 (proband) and 18 years old their 48-year-old father underwent comprehensive ophthalmic evaluations. Multimodal imaging was performed with spectral domain optical coherence tomography, ultrawide field short-wavelength fundus autofluorescence, pseudocolor imaging.

10.1080/13816810.2025.2483421 article EN Ophthalmic Genetics 2025-03-26

CREBBP loss‐of function variants cause Rubinstein–Taybi syndrome (RTS). There have been two separate reports of patients with missense in exon 30 or 31 individuals lacking the characteristic facial and limb dysmorphism associated RTS. Frequent features this condition include variable intellectual disability, short stature, autistic behavior, microcephaly, feeding problems, epilepsy, recurrent upper airway infections, mild hearing impairment. We report three further de novo variants. The...

10.1002/ajmg.a.61131 article EN American Journal of Medical Genetics Part A 2019-03-20

To describe the retinal phenotype of an unusual case anti-TRPM1 autoantibody-positive unilateral melanoma-associated retinopathy (MAR) triggered by nivolumab therapy and compare with

10.1016/j.ajoc.2024.102098 article EN cc-by-nc-nd American Journal of Ophthalmology Case Reports 2024-07-06

Abstract Xia‐Gibbs syndrome (XGS) is a recently described neurodevelopmental disorder due to heterozygous loss‐of‐function AHDC1 mutations. XGS characterized by global developmental delay, intellectual disability, hypotonia, and sleep abnormalities. Here we report the clinical phenotype of five six individuals with identified prospectively at Children's Hospital Philadelphia, tertiary children's hospital in USA. Although all patients demonstrated common features delay characteristic facial...

10.1002/ajmg.a.40380 article EN American Journal of Medical Genetics Part A 2018-08-27

Purpose: The purpose of this study was to compare the natural history visual function change in cohorts patients affected with retinal degeneration due biallelic variants Bardet-Biedl syndrome genes: BBS1 and BBS10. Methods: Patients were recruited from nine academic centers six countries (Belgium, Canada, France, New Zealand, Switzerland, United States). Inclusion criteria were: (1) female or male a clinical diagnosis dystrophy, (2) disease-causing BBS10, (3) measures for at least one...

10.1167/iovs.62.15.26 article EN cc-by-nc-nd Investigative Ophthalmology & Visual Science 2021-12-23
Coming Soon ...